摘要
目的:评价孟鲁司特钠治疗小儿轻中度持续性哮喘效果。方法:均分我院收治的88例小儿轻中度持续性哮喘患者,对照组予以布地奈德气雾剂进行治疗,观察组在此基础上加用孟鲁司特钠进行治疗,对比两组治疗效果。结果:观察组治疗总有效率95.45%,显著高于对照组的81.82%(P<0.05);用药后FEV1和PEF%水平为(88±10)L、(90±9)%显著高于对照组的(72±8)L和(72±7)%,(P<0.05)结论:布地奈德和孟鲁司特钠联合应用于小儿轻中度持续性哮喘中疗效较好值得应用。
Objective Evaluation of Montelukast sodium treatment of infantile asthma mild--to--moderate continuous results. Method Evenly divided 88 cases of children with mild to moderate persistent asthma in our hospital, The control shall be budesonide aerosol treatment, Observation group with budesonide aerosol and Montelukast sodium treatment ,Compared to two groups of therapeutic effect.Result Observe the treatment group total effective rate was 95.45%,Significantly higher than that of control group 81. 82% （P〈 0.05）FEV1 and PEF % level after the use of drugs for （88 ±10）, L （90-9） %, Significantly higher than that of control group（72 ± 8） L and（72 ± 7） % （P〈 0, 05） Conclusion budesonide and meng Montelukastsodium, joint application without mild -- to -- moderate persistent asthma has good curative effect, Worthy of clinical application.
